Please login to the form below

Not currently logged in
Email:
Password:

New president at Bayer Healthcare

Dieter Weinand replaces departing Andreas Fibig
Bayer dieter Weinand

Bayer Healthcare has looked to Otsuka Pharmaceuticals to replace its departing president Andreas Fibig.

Dieter Weinand, who is currently president global commercialisation and portfolio management at Otsuka's US subsidiary, will step into his new role at Bayer Healthcare on August 1.

The announcement comes just one week after Weinand's predecessor Fibig announced his intention to leave Bayer Healthcare to join International Flavors & Fragrances as CEO.

Bayer Healthcare's parent group Bayer also announced this week that group CEO Marijn Dekkers will step down from his role at the end of 2016.

In addition to his time at Otsuka, Weinand boasts an impressive CV, serving across multiple regions and therapy areas for Pfizer and Bristole-Myers Squibb.

This includes roles as Pfizer's president for Asia-Pacific and as president for BMS' operations in Latin America and Canada.

6th June 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics